Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety and efficacy of...
BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high value, traditionally undruggable targets, announced...
Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, announced the launch of a clinical trial...
Synthetic Biologics, Inc., a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, announced it has signed a...
Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction of microbiome-based products, and...
